ISRGINTUITIVE SURGICAL INCSEC EDGAR
Use with Claude or ChatGPT

INTUITIVE SURGICAL INC (ISRG) Overview

Healthcare • Nasdaq • CIK 0001035267

Loading...

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms

Market Cap
$152.50B
P/E (TTM)
51.6x
Rev Growth (TTM)
+20.5%
Net Margin (TTM)
25.5%
FCF Yield (TTM)
2.4%
FCF Margin (TTM)
31.1%
Figures as of September 30, 2026
Data coverage notes

Borrowings: none identified in filed XBRL. MetricDuck reads the common debt concepts; a filer can tag borrowings under one it does not, so this is not evidence the company is debt-free — check the filing before treating debt as zero. Enterprise Value and net-debt figures assume zero borrowings.

Filings

Primary-source SEC disclosures, read end-to-end. SEC figures cite the filing they come from.

8-KNov 20262026-11-02source
10-Q2026 Q32026-10-21source
8-KEarnings2026-10-20source
8-KJul 20262026-07-27source
10-Q2026 Q22026-07-21source
What your agent reads

Investor Relations

investor.intuitivesurgical.com/events-and-presentations

Company-published material — management’s own words, not SEC-audited. Each source below is labeled so your agent knows what to verify.

IR decks — not catalogued
Company-published, not SEC-audited

Earnings

Q3
27 days ago
8-K release
Revenue
$3.05B
—
Net Income
$524.40M
—
EPS
$1.49
-23.6%
Earnings call2025 Q4· machine-transcribedtranscript
Most recent quarterly earnings snapshot

Cash Flow Health

Free Cash Flow8/8 positive
TTM$3.6B
Q3 '26
$1.1B+17%
Q2 '26
$948.4M+17%
FCF Margin
TTM31.1%
Q3 '2636.4%+11%
Sector: 3.3%Top 10%
OCF Margin
35.3%
OCF/NI1.38x
CapEx Coverage
8.3x
FCF Yield2.4%
FCF Growth (3Y)+42%
Cash Conversion Cycle
209 days
DSO: 50+DIO: 187−DPO: 28
Factsheet →
Cash flow trends & capital efficiency

Capital Allocation

Total Shareholder YieldTTM
TTM3.0%
Dividend & Payout Metrics
Dividend Yield (TTM)—
Free Cash Flow (TTM)$3.6B
Stock Repurchases (TTM)$4.6B
Capital Return / FCF128.4%
Shares Outstanding (YoY)-2.3%↓ Buyback
Shows how management rewards shareholders

Valuation Metrics

Price-to-EarningsTTM
51.6x
Volatile
8Q: 63.4x-1429%
High PEG ratio (5.4x) suggests expensive for growth
Valuation Lenses
Earnings
51.6x
vs – sector
Cash Flow
41.3x
EV/FCF vs –
Growth-Adj
5.4xPEG
Expensive for growth
Quality-Adj
3.3P/E per %ROIC
ROIC: 15.4%
Shareholder Returns
Dividend
–
Buyback
3.0%
Total Yield
3.0%
Market Cap$152.50B
EV$148.46B

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms

Multi-angle valuation analysis with sector context

Margins & Efficiency

ROIC 75th pctile
Profitability Cascade
Gross
67.2%
Operating
28.4%
Top 25% in sector
Net
25.5%
Margins Unknown
Return on Invested CapitalTTM
15.4%
Stable
+0.0% YoY8Q: 15.1%-0.7%
P25MedianP75
75th pctl (med: -8.0%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
23.3%
8Q: 25.5%
Asset Turnover
0.57x
8Q: 0.54x
Leverage (1+D/E)
–
Asset & CapEx Efficiency
Fixed Asset Turn
2.13x
8Q:2.08x
+14.0%
Invested Cap Turn
0.87x
8Q:0.84x
+2.0%
CapEx Intensity
3.7%
8Q:3.9%
CapEx/Depreciation
11.25x
FCF vs Net Margin Gap+5.5 pts
Margin trends, ROIC, and capital efficiency

Balance Sheet & Solvency

ND/EBITDA -0.8x
Net Debt / EBITDA
-0.8x
Interest Coverage
–
Leverage Metrics
Debt-to-Equity
–
Balance sheet risk & solvency analysis

Related Research

2 related posts